nsc 664704 has been researched along with Cancer of Liver in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, W | 1 |
| Wu, J | 1 |
| Dong, H | 1 |
| Bouck, D | 1 |
| Zeng, FY | 1 |
| Chen, T | 1 |
1 other study available for nsc 664704 and Cancer of Liver
| Article | Year |
|---|---|
Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells.
Topics: Benzazepines; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cytochrome P-450 CYP3A; Enzym | 2008 |